Citation Impact
Citing Papers
SuFEx-enabled, agnostic discovery of covalent inhibitors of human neutrophil elastase
2019 StandoutNobel
Effective expansion of alloantigen-specific Foxp3 + CD25 + CD4 + regulatory T cells by dendritic cells during the mixed leukocyte reaction
2006 StandoutNobel
Proinflammatory Cytokines in Nasal Secretions of Allergic Subjects after Antigen Challenge
1994
Injection immunotherapy. British Society for Allergy and Clinical Immunology Working Party.
1993
Functional diversity of helper T lymphocytes
1996 StandoutNature
John Snow's legacy: epidemiology without borders
2013 StandoutNobel
Consensus statement * on the treatment of allergic rhinitis
2000
Monophosphoryl lipid A (MPL®)* promotes allergen‐induced immune deviation in favour of Th1 responses
2005
Expression of IL-12 and IL-13 mRNA in asthma and their modulation in response to steroid therapy.
1997
Immunohistology of the nasal mucosa in seasonal allergic rhinitis: Increases in activated eosinophils and epithelial mast cells
1992
Atopic Dermatitis
2008 Standout
Th2 cells and GATA-3 in asthma: new insights into the regulation of airway inflammation
1999
Idiopathic pulmonary fibrosis
2017 Standout
Enhanced nasal cytokine production in human beings after in vivo challenge with diesel exhaust particles
1996
Phenotypic characterization of T cells infiltrating the conjunctiva in chronic allergic eye disease
1996
Monocyte chemotactic and activating factor is a potent histamine-releasing factor for basophils.
1992
Expression of IL-4, Cϵ RNA, and Iϵ RNA in the nasal mucosa of patients with seasonal rhinitis: Effect of topical corticosteroids☆☆☆★★★
1998
Allergen immunotherapy for asthma
2003
Psoriasis
2009 Standout
Safety of Various Dosage Regimens during Induction of Sublingual Immunotherapy
2002
Immunotherapy with an alum‐adsorbed Parietaria‐pollen allergoid: a 2‐year, double‐blind, placebo‐controlled study
1997
Chemokines and leukocyte traffic
1998 StandoutNature
Th1/Th2 Cells
1999
Interleukin-6 and interleukin-1α production is associated with antigen-induced late nasal response
1993
Nuclear Factor-κB — A Pivotal Transcription Factor in Chronic Inflammatory Diseases
1997 Standout
Diagnosis and Management of Rhinitis: Complete Guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology
1998
Eosinophil function in health and disease
1995
Tuberculous Pleurisy
1998
Chemokines — Chemotactic Cytokines That Mediate Inflammation
1998 Standout
Regulation of vascular cell adhesion molecule-1 expression by IL-4 and TNF-alpha in cultured endothelial cells.
1995
Safety Considerations in Assessing the Role of Immunotherapy in Allergic Disorders
1994
IL‐13 production by allergen‐stimulated T cells is increased in allergic disease and associated with IL‐5 but not IFN‐γ expression
1997
Grass pollen sublingual immunotherapy for seasonal rhinoconjunctivitis: a randomized controlled trial
2002
Redirecting Th2 Responses in Allergy
1999
Results of a Home-Based Environmental Intervention among Urban Children with Asthma
2004 Standout
Leukotriene antagonism in asthma and rhinitis
1998
Immunotherapy in asthma: an updated systematic review
1999
Eosinophils express interleukin 5 and granulocyte macrophage-colony-stimulating factor mRNA at sites of allergic inflammation in asthmatics.
1992
Short-term immunotherapy: A prospective, randomized, double-blind, placebo-controlled multicenter study of molecular standardized grass and rye allergens in patients with grass pollen-induced allergic rhinitis☆☆☆★
1997
Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study)
2002
Cellular inflammatory responses during immediate, developing, and established late-phase allergic cutaneous reactions: Effects of cetirizine
1997
Interleukin-5 Gene Expression in Nasal Mucosa and Changes in Amount of Interleukin-5 in Nasal Lavage Fluid After Antigen Challenge
1994
Cytokines in asthma
1999
CD4+ T helper cells engineered to produce latent TGF-β1 reverse allergen-induced airway hyperreactivity and inflammation
2000
Induction of nitric oxide synthase in asthma
1993
Does Allergen Immunotherapy Alter the Natural Course of Allergic Disorders?
2001
Long‐term treatment with allergoid immunotherapy with Parietaria. Clinical and immunologic effects in a randomized, controlled trial
1999
Mechanisms of allergen-specific immunotherapy
2011
Analysis of the Cytokine Pattern Expressed In Situ in Inhalant Allergen Patch Test Reactions of Atopic Dermatitis Patients
1995
Expression of IL-16 in allergen-induced late-phase nasal responses and relation to topical glucocorticosteroid treatment
1997
Grass pollen immunotherapy for seasonal rhinitis and asthma: A randomized, controlled trial
2001
Immunoglobulin E-Binding Structures on Antigen-Presenting Cells Present in Skin and Blood
1995
Pathophysiology of Premature Skin Aging Induced by Ultraviolet Light
1997 Standout
Endothelial adhesion molecules for nasal-homing T cells in allergy
1996
Effect of cetirizine on bronchial hyperresponsiveness in patients with seasonal allergic rhinitis and asthma
2001
Review of the Molecular and Cellular Mechanisms of Action of Glucocorticoids for Use in Asthma
2002
Inflammatory cell populations and cytokine mRNA expression in the nasal mucosa in aspirin-sensitive rhinitis
1999
Tuberculosis in Patients with Human Immunodeficiency Virus Infection
1999 Standout
Cetirizine
1993
Tree‐pollen allergy is efficiently treated by short‐term immunotherapy (STI) with seven preseasonal injections of molecular standardized allergens
1998
Molecular pathology of allergic disease
2000
Evidence for distinct cytokine expression in allergic versus nonallergic chronic sinusitis
1995
Granulocyte macrophage colony-stimulating factor contributes to enhanced monocyte survival in chronic atopic dermatitis.
1995
Intratumoral modulation of the inducible co-stimulator ICOS by recombinant oncolytic virus promotes systemic anti-tumour immunity
2017 StandoutNobel
Inhibition of programmed eosinophil death: a key pathogenic event for eosinophilia?
1995
IL‐3 receptor expression, regulation and function in cells of the Vasculature.
1996
Clinical aspects of allergic disease: A double-blind study of the discontinuation of ragweed immunotherapy
1997
Local nasal immunotherapy with extract in powder form is effective and safe in grass pollen rhinitis: A double-blind study
1996
Granulocyte/Macrophage–Colony Stimulating Factor in Allergen–Induced Rhinitis: Cellular Localization, Relation to Tissue Eosinophilia and Influence of Topical Corticosteroid
1998
Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study
2014
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
Chronic hyperplastic sinusitis: Association of tissue eosinophilia with mRNA expression of granulocyte-macrophage colony-stimulating factor and interleukin-3
1993
Implicating adhesion molecules in nasal allergic inflammation
1995
Type 2 cytokines and negative immune regulation in human infections
1993
Protective effects of deflazacort on allergen-specific conjunctival challenge
1993
Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial
2001 Standout
Increased Expression of Inducible Nitric Oxide Synthase in Nasal Epithelial Cells in Patients With Allergic Rhinitis
1999
TNF α is localized to nasal mucosal mast cells and is released in acute allergic rhinitis
1995
The development of allergic inflammation
2008 StandoutNature
Nasal challenge with allergen upregulates the local expression of vascular endothelial adhesion molecules
1994
Th1 and Th2 subsets: paradigms lost?
1995
Air pollution and health
2002 Standout
Asthma
2001 Standout
Allergic eye disease mechanisms
1998
Nasal application of a gel formulation of N‐acetyl‐aspartyl glutamic acid (NAAGA) compared with placebo and disodium cromoglycate in the symptomatic treatment of pollinosis*
1994
Bilateral increases in histamine after unilateral nasal allergen challenge.
1997
The Cytokine Network in Lesional and Lesion-Free Psoriatic Skin Is Characterized by a T-Helper Type 1 Cell-Mediated Response
1993
Increase in IL-8, IL-10, IL-13, and RANTES mRNA levels (in situ hybridization) in the nasal mucosa after nasal allergen provocation
1999
Effect of Anti-IL-5 and IL-5 on Airway Hyperreactivity and Eosinophils in Guinea Pigs
1993
Allergic rhinitis: Definition, epidemiology, pathophysiology, detection, and diagnosis
2001 Standout
Basophils in airway disease
2002
[16] Animal models of asthma: Role of chemokines
1997
Immunoregulatory mechanisms involved in elicitation of allergic contact hypersensitivity
1998
Heterogeneity of mast cells and T cells in the nasal mucosa
1996
A double-blinded, comparative study of the effects of short preseason specific immunotherapy and topical steroids in patients with allergic rhinoconjunctivitis and asthma
2001
Long-Term Clinical Efficacy of Grass-Pollen Immunotherapy
1999
Gene expression of the GATA-3 transcription factor is increased in atopic asthma
1999
Allergen immunotherapy: Therapeutic vaccines for allergic diseases A WHO position paper
1998 Standout
Immunologic changes associated with allergen immunotherapy
1998
Induction of non-responsiveness in human allergen-specific type 2 T helper cells
1994
Fortnightly review: seasonal allergic rhinitis: Table 1
1997
Soluble interleukin-4 receptor (sIL-4R) in allergic diseases
1999
Evaluation of Impermeable Covers for Bedding in Patients with Allergic Rhinitis
2003
Idiopathic Pulmonary Fibrosis
2001 Standout
Cytokine immunoreactivity in seasonal rhinitis: regulation by a topical corticosteroid.
1995
Pathogenesis of allergic rhinitis
1997
Circulating eosinophil/basophil progenitors and nasal mucosal cytokines in seasonal allergic rhinitis
1999
A comparison of cytokine release from epithelial cells cultured from nasal biopsy specimens of atopic patients with and without rhinitis and nonatopic subjects without rhinitis
1997
Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines.
1994
Increased expression of type 2 cytokines in chronic proliferative dermatitis (cpdm) mutant mice and resolution of inflammation following treatment with IL-12
2001
Immunolocalization of intracellular interleukin‐4 in normal human peripheral blood basophils
1994
Regulation of the development of type 2 T-helper cells in allergy
1994
Immunotherapy with Fel d 1 peptides decreases IL-4 release by peripheral blood T cells of patients allergic to cats
1998
Focal expression of interleukin-2 does not break unresponsiveness to "self" (viral) antigen expressed in beta cells but enhances development of autoimmune disease (diabetes) after initiation of an anti-self immune response.
1995 StandoutNobel
Immunological changes during specific immunotherapy of grass pollen allergy: reduced lymphoproliferative responses to allergen and shift from TH2 to TH1 in T‐cell clones specific for Phi p 1, a major grass pollen allergen
1997
The expanding universe of T-cell subsets: Th1, Th2 and more
1996 Standout
Specific immunotherapy in asthma: Is it effective?
1994
Effect of cetirizine and prednisolone on cellular infiltration and cytokine mRNA expression during allergen‐induced late cutaneous responses
1996
Quantitation of inflammatory cells in the nasal mucosa of patients with allergic rhinitis and normal subjects
1995
Randomized Trial of Peanut Consumption in Infants at Risk for Peanut Allergy
2015 Standout
Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease
2002 StandoutNature
Expression of ε germ‐line gene transcripts and mRNA for the ε heavy chain of IgE in nasal B cells and the effects of topical corticosteroid
1997
Seasonal allergic conjunctivitis is accompanied by increased mast cell numbers in the absence of leucocyte infiltration
1997
Immunotherapy with standardized extract of Dermatophagoides pteronyssinus in bronchial asthma: a dose‐titration study
1997
Tumor necrosis factor-alpha induces mucin hypersecretion and MUC-2 gene expression by human airway epithelial cells.
1995
Eosinophils: Biology and Role in Disease
1995
Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity
2010 StandoutNature
Cytokine expression in the lower airways of nonasthmatic subjects with allergic rhinitis: Influence of natural allergen exposure
2000
Nasal eosinophilia and IL-5 mRNA expression in seasonal allergic rhinitis induced by natural allergen exposure: Effect of topical corticosteroids
1998
The link between the nose and lung, perennial rhinitis and asthma—is it the same disease?
1997
Th‐2 Type Cytokine Receptors in Allergic Rhinitis and in Response to Topical Steroids
1999
Immunological mechanisms of allergen-specific immunotherapy
2006
The Transcription Factor GATA-3 Is Necessary and Sufficient for Th2 Cytokine Gene Expression in CD4 T Cells
1997 Standout
Local production and detection of (specific) IgE in nasal B-cells and plasma cells of allergic rhinitis patients
2000
Development of a new technique for recovery of cytokines from inflammatory sites in situ
1992
Monocyte chemotactic proteins in allergen-induced inflammation in the nasal mucosa: Effect of topical corticosteroids
1999
Cellular infiltration and cytokine mRNA expression in perennial allergic rhinitis
1999
The Concept of Type-1 and Type-2 Helper T Cells and Their Cytokines in Humans
1998
Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis
1995 Standout
House‐dust‐mite sublingual‐swallow immunotherapy (SLIT) in perennial rhinitis: a double‐blind, placebo‐controlled study
2000
Effect of 3 months’ nasal steroid therapy on nasal T cells and Langerhans cells in patients suffering from allergic rhinitis
1995
Soluble Adhesion Molecules and Cytokines in Perennial Allergic Rhinitis
1998
Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsìveness, and the late asthmatic response
2000 Standout
Nasal cytokines in common cold and allergic rhinitis
1995
Antigen-specific regulatory T cells develop via the ICOS–ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity
2002
A double‐blind, placebo‐controlled trial of local nasal immunotherapy in allergic rhinitis to Parietaria pollen
1995
Interleukin-5 and eosinophil cationic protein in nasal lavages of rhinitis patients
1995
Serum markers of collagen synthesis and degradation in skin diseases. Altered levels in diseases with systemic manifestation and during systemic glucocorticoid treatment
1993
β-Arrestin-2 regulates the development of allergic asthma
2003 StandoutNobel
Proinflammatory cytokines in allergic rhinitis
1995
Immunotherapy with Alpare® in patients with respiratory allergy to Parietaria pollen: a two year double‐blind placebo‐controlled study
1995
A double‐blind, placebo‐controlled study of immunotherapy with grass‐pollen extract Alutard SQ during a 3–year period with initial rush immunotherapy
1996
Predominant TH2-like Bronchoalveolar T-Lymphocyte Population in Atopic Asthma
1992 Standout
Influence of prolonged treatment with topical corticosteroid (fluticasone propionate) on early and late phase nasal responses and cellular infiltration in the nasal mucosa after allergen challenge
1994
Clinical efficacy of sublingual‐swallow immunotherapy: a double‐blind, olacebo‐controlled trial of a standardized five‐grass‐pollen extract in rhinitis
1998
The role of T lymphocytes in the pathogenesis of asthma
2003
Therapeutic strategies for allergic diseases
1999 Nature
GM-CSF in inflammation and autoimmunity
2002
Systemic Immunological Changes Induced by Administration of Grass Pollen Allergens via the Oral Mucosa during Sublingual Immunotherapy
1999
Enhanced expression of high-affinity IgE receptor (FcϵRI) α chain in human allergen-induced rhinitis with co-localization to mast cells, macrophages, eosinophils, and dendritic cells☆☆☆★
1997
Specific immunotherapy downregulates peripheral blood CD4 and CD8 T-lymphocyte activation in grass pollen-sensitive asthma
1998
T Cells Are the Principal Source of Interleukin-5 mRNA in Allergen-induced Rhinitis
1993
IL-13 mRNA and Immunoreactivity in Allergen-induced Rhinitis: Comparison with IL-4 Expression and Modulation by Topical Glucocorticoid Therapy
1997
Eotaxin mRNA and Protein Expression in Chronic Sinusitis and Allergen-induced Nasal Responses in Seasonal Allergic Rhinitis
1997
Cytokines as Mediators of Chronic Asthma
1994
Relationship of the Manifestations of Tuberculosis to CD4 Cell Counts in Patients with Human Immunodeficiency Virus Infection
1993
RANTES Induces Nasal Mucosal Inflammation Rich in Eosinophils, Basophils, and Lymphocytes In Vivo
1998
Combined Nasal Challenge with Diesel Exhaust Particles and Allergen Induces In Vivo IgE Isotype Switching
1998
Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant
2009 StandoutNobel
Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo.
1995
CC chemokines in allergic inflammation
1994
Activation of A3 adenosine receptors on human eosinophils elevates intracellular calcium
1996 StandoutNobel
The kinetics of allergen-induced transcription of messenger RNA for monocyte chemotactic protein-3 and RANTES in the skin of human atopic subjects: relationship to eosinophil, T cell, and macrophage recruitment.
1995
Histamine induces IL-6 production by human endothelial cells
1994
In vivo expression of signal transducer and activator of transcription factor 6 (STAT6) in nasal mucosa from atopic allergic rhinitis: effect of topical corticosteroids
2000
Sublingual immunotherapy with a standardised grass pollen extract; a double-blind placebo-controlled study.
1999
Systems analysis identifies an essential role for SHANK-associated RH domain-interacting protein (SHARPIN) in macrophage Toll-like receptor 2 (TLR2) responses
2011 StandoutNobel
Mouse Eotaxin Expression Parallels Eosinophil Accumulation during Lung Allergic Inflammation but It Is Not Restricted to a Th2-Type Response
1996
IL‐10‐induced anergy in peripheral T cell and reactivation by microenvironmental cytokines: two key steps in specific immunotherapy
1999
Assessment by Nasal Biopsy of Long‐Term Use of Mometasone Furoate Aqueous Nasal Spray (Nasonex) in the Treatment of Perennial Rhinitis
1998
Symptom control in patients with hay fever in UK general practice: how well are we doing and is there a need for allergen immunotherapy?
1998
Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals.
1993
Programmed assembly of 3-dimensional microtissues with defined cellular connectivity
2009 StandoutNobel
GM‐CSF, IL‐5 and RANTES immunoreactivity and mRNA expression in chronic hyperplastic sinusitis with nasal polyposis (NP)
1998
Requirement for IL-13 Independently of IL-4 in Experimental Asthma
1998 StandoutScience
Nonviral Vectors for Gene Delivery
2008 Standout
Human peripheral blood basophils primed by interleukin 3 (IL-3) produce IL-4 in response to immunoglobulin E receptor stimulation.
1993
Long‐term effects of corticosteroid nasal spray on nasal inflammatory cells in patients with perennial allergic rhinitis
1999
Early and late allergic reaction in the nose assessed by whole body plethysmography
1996
Effect of topical corticosteroids on seasonal increases in epithelial eosinophils and mast cells in allergic rhinitis: a comparison of nasal brush and biopsy methods
1999
A comparison of randomised controlled trials in health and education
2005
Interleukin‐8 secretion in patients with allergic rhinitis after an allergen challenge: interleukin‐8 is not the main chemotactic factor present in nasal lavages
1997
Submucous turbinectomy decreases not only nasal stiffness but also sneezing and rhinorrhea in patients with perennial allergic rhinitis
1999
Allergy and Allergic Diseases
2001
Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2
1997 StandoutNobel
Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity.
1996
Topical glucocorticosteroid (fluticasone propionate) inhibits cells expressing cytokine mRNA for interleukin-4 in the nasal mucosa in allergen-induced rhinitis.
1994
Expression and generation of interleukin-8, IL-6 and granulocyte-macrophage colony-stimulating factor by bronchial epithelial cells and enhancement by IL-1 beta and tumour necrosis factor-alpha.
1992
Eotaxin Induces a Rapid Release of Eosinophils and Their Progenitors From the Bone Marrow
1998
Immunotherapy as an effective tool in allergy treatment
1998
Position Paper: Immunotherapy
1993
In vivo expression of cytokine receptor mRNA in atopic dermatitis
1998
Interleukin 4 is localized to and released by human mast cells.
1992
Effect of Acupuncture in the Treatment of Seasonal Allergic Rhinitis: A Randomized Controlled Clinical Trial
2002
IL-4 secretion and histamine release by human basophils are differentially regulated by protein kinase C activation
1998
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
2005 Standout
Vigorous HIV-1-Specific CD4 + T Cell Responses Associated with Control of Viremia
1997 StandoutScience
Allergic rhinitis in children: effects of flunisolide and disodium cromoglycate on nasal eosinophil cationic protein
1997
Th1/Th2 cells
2007
Relationship between nasal hyperreactivity, mediators and eosinophils in patients with perennial allergic rhinitis and controls
1996
β-Arrestin-2 regulates the development of allergic asthma
2003 StandoutNobel
Lack of Evidence for the Dichotomy of T H 1 and T H 2 Predominance in HIV-Infected Individuals
1994 Science
Functional deficiencies of granulocyte-macrophage colony stimulating factor and interleukin-3 contribute to insulitis and destruction of β cells
2007 StandoutNobel
Grass Pollen Immunotherapy Induces Mucosal and Peripheral IL-10 Responses and Blocking IgG Activity
2004
Interleukin-13: Central Mediator of Allergic Asthma
1998 StandoutScience
Influenza Virus–induced Dendritic Cell Maturation Is Associated with the Induction of Strong T Cell Immunity to a Coadministered, Normally Nonimmunogenic Protein
2003 StandoutNobel
Pleural Effusion
2002 Standout
T lymphocytes and mast cells express messenger RNA for interleukin-4 in the nasal mucosa in allergen-induced rhinitis.
1994
The effect of fluticasone propionate aqueous nasal spray on nasal mucosal inflammation in perennial allergic rhinitis
1995
Increased nitric oxide in nasal lavage fluid and nitrotyrosine formation in nasal mucosa — indices for severe perennial nasal allergy
1998
Short‐term preseasonal birch pollen allergoid immunotherapy influences symptoms, specific nasal provocation and cytokine levels in nasal secretions, but not peripheral T‐cell responses, in patients with allergic rhinitis
1999
Tolerogenic Dendritic Cells
2003 StandoutNobel
Local Corticosteroid Treatment: The Effect on Cells and Cytokines in Nasal Allergic Inflammation
1998
Increase in Expression of IL-4 and IL-5 Mrna in the Nasal Mucosa of Patients with Perennial Allergic Rhinitis during Natural Allergen Exposure
1997
HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation
2004 StandoutNobel
Cytokines and Adhesion Molecules in Allergic Rhinitis
1998
Position Paper: Allergen standardization and skin tests
1993
High‐affinity immunoglobulin E receptor (FcεRI)‐bearing eosinophils, mast cells, macrophages and Langerhans’ cells in allergen‐induced late‐phase cutaneous reactions in atopic subjects
1998
CD30 and type 2 T helper (Th2) responses
1995
Idiopathic Pulmonary Fibrosis
2018 Standout
Bronchial biopsies and airway inflammation
1996
ATP transduces signals from ASGM1, a glycolipid that functions as a bacterial receptor
2001 StandoutNobel
Allergen injection immunotherapy for seasonal allergic rhinitis
2007
Inducible ablation of mouse Langerhans cells diminishes but fails to abrogate contact hypersensitivity
2005 StandoutNobel
Latex allergy in a dental nurse: Late nasal response is associated with eosinophil recruitment and T helper 2 cell type cytokine mRNA expression
1998
Works of Veronica Varney being referenced
Hayfever in the United Kingdom
1991
Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses.
1993
Immunotherapy and allergic inflammation
1991
Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-γ
1996
A double blind randomised placebo controlled pilot study of oral co-trimoxazole in advanced fibrotic lung disease
2007
Immunohistology of the Nasal Mucosa Following Allergen-induced Rhinitis: Identification of Activated T Lymphocytes, Eosinophils, and Neutrophils
1992
TNFα mRNA expression in allergic inflammation
1991
Preferential messenger RNA expression of Th1-type cells (IFN-gamma+, IL-2+) in classical delayed-type (tuberculin) hypersensitivity reactions in human skin
1992
Grass pollen immunotherapy: efficacy and safety during a 4‐year follow‐up study
1995
274 Localization of cells expressing mRNA for the cytokine gene cluster, IL-3, IL-4, IL-5 and GM-CSF in allergen-induced cutaneous late-phase reactions in atopic patients
1991
Clinical efficacy of specific immunotherapy to cat dander: a double‐blind placebo‐controlled trial
1997
Cytokine messenger RNA expression for IL-3, IL-4, IL-5, and granulocyte/macrophage-colony-stimulating factor in the nasal mucosa after local allergen provocation: relationship to tissue eosinophilia
1992
Messenger RNA expression of the cytokine gene cluster, interleukin 3 (IL-3), IL-4, IL-5, and granulocyte/macrophage colony-stimulating factor, in allergen-induced late-phase cutaneous reactions in atopic subjects.
1991
Eosinophil activation and T lymphocyte infiltration in allergen-induced late phase skin reactions and classical delayed-type hypersensitivity
1991
Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs.
1991
The effect of a single oral dose of prednisolone or cetirizine on inflammatory cells infiltrating allergen‐induced cutaneous late‐phase reactions in atopic subjects
1992